What the analyst said

Citi analyst Tyler Radke lowered the price target on Oracle (NYSE: ORCL) to $310.00 (from $370.00) while maintaining a Buy rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $115. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $310 target is 33% above the median.

Since the note ORCL has moved −23% (from $149). 12-month window: day 246 of 365, closes on March 4, 2027.

Track record

This callOpen: ORCL has not reached $310 yet. This 12-month target is scored on March 4, 2027.

Firm track recordCiti: 88% of its 40 targets at least a year old were reached within 12 months (#4 of 26 firms). Accuracy ranking →

Citi on Oracle

Citi price targets on Oracle

2 calls from March 4, 2026 to June 4, 2026. The target went from $310 to $330 (+6%). The rating stayed Buy.

Citi targetORCL share price
  1. June 4, 2026Target raised from $310 (+6%)Buy$330
  2. March 4, 2026 This noteEarliest call shownBuy$310
Share

Other analysts on Oracle

ScotiabankBuy Cut price target −5%, kept rating Oct 29 $205from $215 GuggenheimBuy Kept rating and price target Oct 29 $400maintained OppenheimerBuy Kept rating and price target Oct 29 $275maintained BairdBuy Kept rating and price target Oct 29 $215maintained Melius ResearchBuy Kept rating and price target Oct 29 $170maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.